Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Perspectives] The Lancet Technology: pharming blood

In 2008, the US Defense Advanced Research Projects Agency (DARPA), whose previous projects have yielded technologies such as the internet, stealth technology, and miniaturised GPS, launched its Blood Pharming programme and called for scientists and clinicians to create a system to manufacture red blood cells for transfusion. “Red blood cells are the most transfused blood product in battlefield trauma care and in civilian clinical settings. The high demand for blood transfusions poses a real challenge”, explains Renee Wegrzyn, DARPA Program Manager.